GO TEAM: Glucose Optimization Through Technology Assisted Management
Black/African American children and young adults with type 1 diabetes are less likely to use diabetes technologies, such as continuous glucose monitors, insulin pumps, and automated insulin delivery systems, compared to White children and young adults. The investigators are working to find ways to make sure that all patients with type 1 diabetes are equally able to use these technologies. The purpose of this study is to find out if a new computer program for the diabetes team, along with a smartphone app (called Glucosano) for patients/parents, as well as a community health worker, are accepted and used by Black/African American patients and parents living with type 1 diabetes, and if this can help decrease racial disparities in the use of diabetes technologies.
Conditions:
🦠 Type 1 Diabetes
🗓️ Study Start (Actual) 29 January 2024
🗓️ Primary Completion (Estimated) 1 October 2026
✅ Study Completion (Estimated) 1 October 2026
👥 Enrollment (Estimated) 60
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Cleveland, Ohio, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Self-reported as Non-Hispanic Black
    • * Clinical diagnosis of T1D requiring treatment with insulin at the time of consent
    • * Not currently (within the past 3 months) using an automated insulin delivery system \\
    • * Willingness to wear a continuous glucose monitor for 10 days at 3 different time points, and willingness to consider use of a personal continuous glucose monitor

    Exclusion Criteria:

    • * Clinical diagnosis of Type 2 or monogenic diabetes
    • * Completed high school
    • * Non-English speaking guardians
    • * Automated insulin delivery system use within the past 3 months
    • * Custody of children and family services
Ages Eligible for Study: 8 Years to 18 Years (CHILD, ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 3 October 2023
  • First Submitted that Met QC Criteria 3 October 2023
  • First Posted 10 October 2023

Study Record Updates

  • Last Update Submitted that Met QC Criteria 29 January 2024
  • Last Update Posted 31 January 2024
  • Last Verified January 2024